Firms
Theme

HEI

HEICO Corporation · NYSE

News

8 latest

Zacks Investment Research

Does Heico (HEI) Have the Potential to Rally 26.83% as Wall Street Analysts Expect?

Heico Corporation (HEI) has gained 4.1% over the past four weeks and trades at $308.64. Wall Street analysts have set a mean price target of $391.46, suggesting a potential 26.8% upside.

Zacks Investment Research

How to Find Strong Buy Aerospace Stocks Using the Zacks Rank

The article explains the Zacks Rank, a proprietary stock-rating model that uses earnings estimate revisions to help investors build winning portfolios. The system evaluates stocks based on four factors: Agreement, Magnitude, Upside, and Surprise.

Zacks Investment Research

Zacks Investment Ideas feature highlights: CoreWeave, Cinemark, Oscar Health and Heico

Despite recent market volatility driven by AI concerns, rising rates, and geopolitical tensions, three stocks with strong Zacks Rank #1 ratings stand out: Cinemark benefits from theater attendance recovery and pricing power, Oscar Health is transitioning to profitability with surging membership growth, and Heico demonstrates consistent aerospace and defense sector strength. All three show improving earnings estimates and constructive technical setups independent of AI boom dependency.

Zacks Investment Research

3 Top Ranked Stocks Gaining Despite Market Turmoil

Amid market volatility triggered by rising interest rates, inflation concerns, and AI sector weakness, three stocks with strong earnings momentum stand out: Cinemark benefits from theater attendance recovery and pricing power, Oscar Health is transitioning to profitability with surging membership growth, and HEICO demonstrates consistent aerospace and defense sector strength. All three carry Zacks Rank #1 ratings and offer exposure outside the dominant AI investment theme.

Zacks Investment Research

The Zacks Analyst Blog Highlights HEICO, ATI and Teledyne

Zacks recommends three aerospace-defense equipment stocks with strong growth potential. HEICO Corp. (Rank #1) benefits from sustained demand for aftermarket parts and recent acquisitions, with 33.6% upside potential.

Zacks Investment Research

Heico (HEI) is an Incredible Growth Stock: 3 Reasons Why

Heico Corporation (HEI) is identified as an attractive growth stock with a Zacks Rank #2 (Buy) and Growth Score of B. The company demonstrates strong fundamentals including 27.6% projected EPS growth (vs. 19.1% industry average), 28.6% year-over-year cash flow growth (vs. 24.1% industry average), and positive earnings estimate revisions, making it a solid choice for growth investors.

Zacks Investment Research

All You Need to Know About Heico (HEI) Rating Upgrade to Strong Buy

Heico Corporation (HEI) has been upgraded to a Zacks Rank #1 (Strong Buy) rating due to upward revisions in earnings estimates over the past three months. The upgrade reflects improving business fundamentals, with analysts raising consensus estimates by 5.4%. Zacks Rank #1 stocks, representing the top 5% of covered companies, have historically generated average annual returns of +25% since 1988.

Zacks Investment Research

New Strong Buy Stocks for October 2nd

Five companies have been added to the Zacks Rank #1 (Strong Buy) list based on increasing earnings consensus estimates over the last 60 days. The stocks include Gray Media (multimedia), Vicor (power components), Embraer (aircraft manufacturing), Demant (hearing healthcare), and Heico (aircraft components).

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $HEI · 0 threads

Sign in to post on $HEI

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev